Endogenous tissue-type plasminogen activator and risk of myocardial infarction
- 1 May 1993
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 341 (8854) , 1165-1168
- https://doi.org/10.1016/0140-6736(93)90998-v
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- An epidemiologic assessment of thrombotic risk factors for cardiovascular diseaseCurrent Opinion in Lipidology, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- Impaired fibrinolysis and risk of thromboembolismProgress in Cardiovascular Diseases, 1991
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Plasma tissue plasminogen activator levels in patients with coronary heart diseaseThrombosis Research, 1988
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrationsJournal of the American College of Cardiology, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Plasminogen activator inhibitor in the blood of patients with coronary artery disease.BMJ, 1985
- Disordered “fibrinolytic potential” in coronary heart diseaseThrombosis Research, 1977